Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials

September 1, 2020 updated by: Yong Hur, Tufts University

The purpose of this pilot study is to conduct a interventional prospective clinical trial to evaluate the efficacy of three different xenografts for ridge preservation by comparing the quality of newly formed bone using histomorphometric and micro CT analysis.The three xenograft materials under investigation are Bio-Oss® (bovine derived xenograft), Equimatrix® (equine derived xenograft), and Endobon® (bovine derived xenograft). There are no prospective studies comparing the effectiveness of these three materials, Bio-Oss®, Endobon® and Equimatrix®, when placed in extraction sockets.

Participants will be recruited from patients in the TUSDM clinics that require extraction of single rooted non-molar tooth and are treatment planned to receive dental implants in the future. Participants will be randomized to receive one of the three xenograft materials after tooth extraction. The percentage of newly formed bone and bone density will be compared between the three materials 4-6 months after ridge preservation.

Study Overview

Status

Completed

Conditions

Detailed Description

This is a pilot prospective clinical trial in which histological and micro CT analysis will be utilized to compare between Endobon®, Equimatrix®, and Bio-Oss®.

Primary aim: Compare the percentage of newly formed bone between Equimatrix®, Bio-Oss® and Endobon®.

The investigators hypothesize that the mean percentage of newly formed bone from Equimatrix® will be higher than Bio-Oss® and/or Endobon®.

Secondary aim: Compare the bone density between Equimatrix®, Bio-Oss® and Endobon®.

The investigators hypothesize that the bone density from Equimatrix® will be higher than Bio-Oss® and/or Endobon®.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02111
        • Tufts University School of Dental Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Non-restorable single rooted tooth in anterior or premolar region
  • Patient previously treatment planned for implant procedure and implant restoration.
  • > 10 mm from maxillary sinus or inferior alveolar canal (IAC)
  • Intact buccal bone (only minor dehiscence or fenestrations (approximately < 50% of socket depth) can be accepted
  • Non-smokers.
  • Patients treatment planned for extraction and ridge preservation at Tufts University School of Dental Medicine.

Exclusion Criteria:

  • Poor oral hygiene (plaque index>30%).
  • Systemic diseases that affect bone metabolism:

    i. Osteoporosis ii. Osteomalacia iii. Hyperthyroidism iv. Hyperparathyroidism v. Paget's disease

  • Inflammatory and autoimmune diseases of the oral cavity (severe bone loss) (self-report):

    i. Severe chronic periodontitis ii. Aggressive periodontitis iii. Necrotizing ulcerative periodontitis iv. Crohn's disease v. Multiple sclerosis vi. Rheumatoid arthritis vii. Systemic lupus erythematosus

  • History of radiation to the head and neck, and /or chemotherapy.
  • Current corticosteroid therapy.
  • History of IV Bisphosphonates therapy or >3 years of oral intake.
  • Infectious diseases such as HIV, tuberculosis, Hepatitis (self-report).
  • Known allergy to research related materials.
  • Self-reported pregnancy or lactation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Equimatrix®
Equimatrix® + Mucograft or alternatives
Ridge preservation bone grafting after tooth extraction
EXPERIMENTAL: Bio-Oss®
Bio-Oss® + Mucograft or alternatives
Ridge preservation bone grafting after tooth extraction
EXPERIMENTAL: Endobon®
Endobon® + Mucograft or alternatives
Ridge preservation bone grafting after tooth extraction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percent New Bone Formation
Time Frame: 4-6 months after ridge preservation surgery
Histomorphometric determination of % new bone formation
4-6 months after ridge preservation surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bone Density
Time Frame: 4-6 months after ridge preservation surgery
Measured by Micro CT Scanning
4-6 months after ridge preservation surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yong Hur, DDS, DMD, MS, Tufts University School of Dental Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 20, 2014

Primary Completion (ACTUAL)

June 7, 2016

Study Completion (ACTUAL)

December 7, 2016

Study Registration Dates

First Submitted

May 9, 2017

First Submitted That Met QC Criteria

May 9, 2017

First Posted (ACTUAL)

May 11, 2017

Study Record Updates

Last Update Posted (ACTUAL)

September 25, 2020

Last Update Submitted That Met QC Criteria

September 1, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alveolar Bone Loss

Clinical Trials on Equimatrix®

3
Subscribe